Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By stimulating these https://lilyhbzi448531.thechapblog.com/35280578/tirzepatide-a-promising-new-treatment-for-obesity